Two Sigma Investments, LP Immuno Gen, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $15.8 Million - $37.9 Million	-1,264,317 Reduced 77.65%	363,900 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $11.5 Million - $16.1 Million	812,680 Added 99.65%	1,628,217 $25.8 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $3.15 Million - $16.8 Million	-838,865 Reduced 50.71%	815,537 $15.4 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $1.18 Million - $1.59 Million	-322,725 Reduced 16.32%	1,654,402 $6.35 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $2.04 Million - $2.82 Million	-447,630 Reduced 18.46%	1,977,127 $9.81 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $1.79 Million - $2.58 Million	399,130 Added 19.7%	2,424,757 $11.6 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $189,645 - $346,780	-60,205 Reduced 2.89%	2,025,627 $9.12 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $2.02 Million - $3.55 Million	-474,942 Reduced 18.55%	2,085,832 $9.93 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $2.35 Million - $3.71 Million	494,108 Added 23.91%	2,560,774 $19 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $4.02 Million - $5.27 Million	-800,076 Reduced 27.91%	2,066,666 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $1.77 Million - $2.63 Million	306,113 Added 11.95%	2,866,742 $18.9 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $3.44 Million - $5.58 Million	529,759 Added 26.09%	2,560,629 $20.7 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $1.45 Million - $3 Million	391,428 Added 23.88%	2,030,870 $13.1 Million
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $1.91 Million - $2.71 Million	553,789 Added 51.01%	1,639,442 $5.9 Million
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $76,881 - $123,658	-23,157 Reduced 2.09%	1,085,653 $4.99 Million
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $239,933 - $769,596	113,176 Added 11.37%	1,108,810 $3.78 Million
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $1.84 Million - $4.74 Million	817,383 Added 458.56%	995,634 $5.08 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $951,665 - $1.45 Million	-428,678 Reduced 70.63%	178,251 $431,000
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $14,491 - $26,568	-8,051 Reduced 1.31%	606,929 $1.32 Million
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $1.19 Million - $2.91 Million	-491,899 Reduced 44.44%	614,980 $1.67 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $4.21 Million - $10.4 Million	1,068,008 Added 2747.57%	1,106,879 $5.31 Million
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $334,290 - $437,687	38,871 New	38,871 $368,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $2.13 Million - $2.71 Million	-223,216 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $5.34 Million - $10.3 Million	-796,873 Reduced 78.12%	223,216 $2.35 Million
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $3.25 Million - $5.07 Million	640,669 Added 168.85%	1,020,089 $6.54 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $2.05 Million - $3.21 Million	379,420	379,420 $2.9 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account